Psychosomatic Medicine Market Analysis and Reports | UK Conference Series

Market Analysis - Psychosomatic Medicine-2020

Importance of Psychiatry

About 14% of the global burden of disease has been attributed to neuropsychiatric disorders, as by 2020, it is estimated to be that the burden of a mental disorder will have to be increased to 15 % of the Disability Adjusted Life Years, which is termed to be (DALYs). Mostly due to the regularly disabling nature of depression and other common mental disorders, alcohol-use and psychosis. Such estimates have drawn helpfulness to the importance of mental disorders for public health. The problem of mental disorders is likely to have been misjudged because of inadequate appreciation of the connectedness between psychological illness and other health disorders.

Conversely, many health situations increase the risk for mental disorder, and comorbidity complicates help-seeking, diagnosis, and behavior, and influences prognosis. Mental disorders, a highly prevalent group of non-communicable diseases, affect the lives of 1 out of 5 persons each year. They represent 20–40% of the burden of disability. Factors related to mental illness can interfere with the treatment of other illnesses and frequently co-occur with CVS, diabetes, cancer, and other non-communicable diseases

Psychiatry is more vital to the common public than ever before, and with the rise of reported mental health and behavior health issues, it might seem a bit confusing as to why personalities still tend to ignore the consequences of leaving these symptoms crude. The Center for Disease Control and Prevention (CDC) has reported that the suicide rate of Americans aged 35-64 years has risen almost 29 percent from 1999 to 2010.  In Europe, the rate of employees reporting mental health issues to their employers has risen to two out of every five workers. Tremendous amounts of studies, an increase in global awareness and a shift in attitude towards treating and helping those with behavioral or mental health issues has likely brought more of these issues to light.kl

Treating the behavior or mental health signs is just one part of the equation – we also are able to effort on one’s overall health, such as eating right, basic medical situations or physical activity. So when you invest in modern psychiatric services, it is a experienced program that addresses all of the needs in a patient’s personal life.

Principles of Psychosomatic

The term psychosomatic, in common parlance and in the medical community, connotes physical symptoms that are not medically legitimate. At least two national organizations with the term in their titles have given serious consideration to changing it. It implies physical symptoms without organic concomitants, triggered by emotional conflict, exaggerated emotionality, stress, and or a desire for attention or other personal benefit. It tends to be dismissive; psychosomatic illnesses are thought to consume inordinate amounts of medical attention and are not deemed worthy of that investment. Prejudices such as these belie the intrinsic interrelatedness of 'psyche' and 'soma', deter scientific investigation into a fascinating interface, and ultimately add to the waste of medical resources.

Psychosomatic medicine poses and addresses critical questions about relationships among 'mind', 'body', the central nervous system, and neuroendocrine functions. It is paradoxical that both medical theory and lay parlance assume that Psychologic, neurologic, and somatic functions and symptoms affect one another closely. The same culture that may deride 'psychosomatic' symptoms accepts without question the observation that a person anticipating an examination experiences “butterflies in the stomach”, that someone got so upset he or she “had a heart attack”, and the idea that stress “eats one's heart out”. Physicians are as vulnerable to these positive and negative preconceptions as the rest of the population and must be alert for their unwitting intrusion into medical reasoning and medical care.

Why to Attend?

Psychiatry & Psychosomatic medicine conference 2020 will provide an opportunity for all stakeholders working on mental health issues to talk about their work. Psychiatry & Psychosomatic medicine meetings 2020 will congregate renowned speakers, principal investigators, experts, psychiatrist and researchers from both academia and health care. Industries will join together to discuss their views and research. Psychiatry & Psychosomatic Medicine conference will be comprised of sessions by world class experts in the field of psychiatry. In Psychiatry & Psychosomatic medicine meetings 2020, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Psychiatry.

A Unique Chance for Advertisers and Sponsors at this Global event:

AFFILIATED SOCIETIES AND ASSOCIATIONS RELATED TO PSYCHIATRY AND PSYCHOSOMATIC MEDICINE.

GLOBALLY

·         The American Psychosomatic society

·         The Japanese Society of Psychosomatic internal medicine.

·         International Society of Ethical Psychology and Psychiatry

·         Brazilian Psychiatric Association

·         American Psychiatric Association

·         Professional association of specialists in psychosomatic

·         Psychosomatic associations in internal diseases

·         Asian Cognitive Behavioral Therapy Association

·         World Psychiatric Association

·         Active Minds

·         American Association of Suicidology

·         American Foundation for Suicide Prevention

·         Brain and Behavior Research Foundation

·         Center for Psychiatric Rehabilitation

·         The National Association of Psychiatric Health Systems.

·         The National Alliance on Mental Illness.

·         The Australian & New Zealand Association of Psychiatry, Psychology and Law

·         Psychotherapy and Counseling Federation of Australia

·         Australian Society for Psychological Medicine

·         The European Association of Psychosomatic medicine.

·         European Mental Health association

TOP UNIVERSITIES FOR PSYCHIATRY AND PSYCHOSOMATIC MEDICINE

Globally

·         Harvard University

·         Stanford University

·         Yale University

·         Columbia University

·         UCLA (University of California Los Angeles)

·         Duke University

·         University of Pennsylvania

·         University of California - San Diego

·         University of Pittsburgh

·         University of Michigan

·         University of Manchester

·         Cardiff University

·         University of Vermont

·         University of Amsterdam

·         University of Melbourne

·         University of Queensland

·         University of New South Wales

·         University of Hong Kong

·         Mount St. Vincent University

·         St. Mary's University

Top Companies Producing Psychosomatic Drugs

·         Forest Laboratories

·         Solvay of Belgium

·         GlaxoSmithKline

·         Pfizer

·         Lund Beck

·         Bristol-Meyer Squibb

·         Oregano International

·         Universal Health Services Inc.

·         Fujisawa Pharmaceutical

·         Meiji Seika

·         Janssen Ph.

·         Novartis

·         Merck

·         Johnson and Johnson

·         Roche

TARGET AUDIENCE:

·         Psychiatry Scientists/Research Professors

·         Physicists/Chemists

·         Junior/Senior research fellows of Psychology Field

·         Directors of Pharmaceutical companies

·         Members of different Psychiatry associations.

.         Student from psychology department